Newsletter | July 23, 2026

07.23.26 -- The Hidden Risk In Choosing A CDMO By RFP Alone

SPONSOR

Cell Bank Manufacturing

Your master cell bank (MCB) is critical to therapeutic product development, in addition to supporting clinical development, manufacturing, and commercial supply of biologics. Put your bank in the hands of the experts and get it right the first time.

FOCUS ON OUTSOURCING

CDMO Selection: Start With The Relationship, Not The RFP

Friction often comes from unspoken expectations. Before production begins, treat the combined sponsor-CDMO group as one extended team and intentionally make “how we work together” visible.

Digging Into Manufacturing Priorities For Viral Vectors

Addressing the complexities of viral vector manufacturing through strategic internalization, advanced technologies, and regulatory excellence is crucial for the future of gene therapies.

Streamlining AAV And LVV Manufacturing Platform Solutions

Observe how streamlined, scalable platforms are transforming viral vector manufacturing to accelerate the delivery of cell and gene therapies to patients.

Redefining Value In Biologics Outsourcing Partnerships

Biologics outsourcing is shifting to strategic partnerships focused on modality expertise, regulatory excellence, and integrated end-to-end capabilities.

Patient-Centricity: Advanced Filling Solutions For Next-Gen Delivery

Leveraging early-stage collaborations and flexible delivery systems can help navigate complex regulatory landscapes while accelerating the delivery of safe, self-administered injectable therapies.

Delivering CDMO Excellence, Quality, And Value Through Dedication

A biologics CDMO combines scientific expertise, flexibility, and partnership to deliver high-quality, cost-efficient development and manufacturing solutions from early stages to commercialization.

Mammalian Expression

See how a biotechnology company advanced an engineered protein therapeutic while navigating development, regulatory, and scalability challenges. 

Optimizing Outcomes In ADC Manufacturing

As bioconjugates evolve, optimized conjugation and strong process and analytical strategies are essential for ensuring consistent quality, targeted characteristics, and reliable therapeutic performance.

(Cross-) Contamination Control Through Effective Equipment Cleaning

Discover science-driven cleaning strategies that reduce cross-contamination, enable safe multiproduct manufacturing, and support faster, flexible GMP changeovers.

ESACT 2026: Reducing Variability With Animal‑Origin‑Free Peptones

Explore how data‑driven collaboration and animal‑origin‑free media strategies can reduce variability, improve cell culture performance, and support consistent, cost‑effective bioprocessing at scale.

What Can You Do To Improve Your ADC's Chance Of Clinical Success?

Improving your ADC’s chance of clinical success requires an understanding of what potential obstacles lie ahead and what capabilities and expertise are necessary to overcome them.

Leading Initiatives That Align Technology, Systems, And Processes

Learn the strategy for achieving sustainable growth through organizational transformation. Systematic digitization and right-sized automation set the stage for next-level operational excellence.

ICP-MS And ICP-OES: Tools For Elemental Impurity Analysis

Leverage advanced elemental impurity testing methods to ensure the safety, compliance, and accuracy of your drug products throughout the manufacturing process.

Innovation For Subcutaneous Delivery Of Large-Volume Complex Biologics

Examine the key findings of a new wearable injector clinical trial, including its positive impact on patient experience and the broader benefits of wearable injectors for chronic disease management.

OUTSOURCING SOLUTIONS

Robust, Flexible Cell Lines That Fit Your Strategy - Abzena

Regulatory Confidence, Manufacturing Excellence - Jubilant HollisterStier

Capabilities Update May 2026: Mammalian Cell Culture - KBI Biopharma

Biologic Development: Solutions For Speed, Flexibility - Thermo Fisher Scientific

Meet The Demands Of Today To Help Ensure The Possibility Of Tomorrow - Kindeva

Genetic Medicines, From Idea To Impact - ElevateBio

SPONSOR

Technology transfers can make or break an ADC program, with process and analytical knowledge often spread across multiple partners and teams. Join Bioprocess Online for an interactive discussion with experts as they share practical strategies for managing technology transfers, reducing risk, and preventing costly delays in ADC development. Register today for free thanks to sponsors CPC Biotech, Samsung Biologics and MilliporeSigma.

Connect With Bioprocess Online: